At NINGBO INNO PHARMCHEM CO., LTD., we understand that the efficacy of pharmaceutical products hinges on the quality of their foundational ingredients. Lidocaine Base (CAS No. 137-58-6), a critical component in the production of local anesthetics, exemplifies this principle. Its designation as USP/BP quality lidocaine base is not merely a label but a guarantee of purity and consistency, essential for patient safety and therapeutic success.

Lidocaine Base, also known by its chemical name N-Diethylacethyl-2,6-Dimethylaniline, is a white crystalline powder. Its physical properties, including its solubility – being soluble in ethanol, benzene, chloroform and oils, and dissoluble in water – are carefully controlled to meet pharmaceutical manufacturing requirements. These properties are foundational for its role as the primary raw material for amide local anesthetic synthesis.

The rigorous standards of the United States Pharmacopeia (USP) and the British Pharmacopoeia (BP) are critical benchmarks in the pharmaceutical industry. When Lidocaine Base meets these standards, it signifies that the compound has undergone stringent testing for identity, strength, quality, and purity. This ensures that it is free from harmful impurities and will perform predictably in subsequent synthesis steps to create lidocaine hydrochloride. This adherence to chemical industry quality standards is non-negotiable for any reputable supplier.

The impact of high-quality Lidocaine Base extends directly to its applications in various anesthesia types, from surface numbing to more complex nerve blocks. Ensuring the purity of this amide anesthetic is vital for preventing adverse reactions and guaranteeing the intended pharmacological effect. Professionals in pharmaceutical raw material sourcing consistently prioritize suppliers who can provide assurance of such quality.

NINGBO INNO PHARMCHEM CO., LTD. is committed to upholding these high standards, offering Lidocaine Base that meets USP/BP specifications. By prioritizing quality assurance, we aim to empower our clients in the pharmaceutical sector to produce safe, effective, and reliable anesthetic medications that are crucial for patient care across numerous medical disciplines.